![Zoran Zdraveski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Zoran Zdraveski
General Counsel bei
TSCAN THERAPEUTICS, INC.
Vermögen: 3 504 $ am 31.07.2026
Profil
Zoran Zdraveski is currently Secretary, Chief Legal & Strategy Officer at TScan Therapeutics, Inc. since 2021.
Formerly, Dr. Zdraveski was Vice President & Associate General Counsel at Epizyme, Inc. from 2012 to 2017 and Secretary & Chief Legal Officer at Magenta Therapeutics, Inc. from 2017 to 2021.
Education includes undergraduate and graduate degrees from Southern Methodist University, a graduate degree from Suffolk University Law School conferred in 2007, and a doctorate from the Massachusetts Institute of Technology conferred in 2002.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.01.2026 | 4’716 ( 0.01% ) | 3 504 $ | 31.07.2026 |
Aktive Positionen von Zoran Zdraveski
| Unternehmen | Position | Beginn |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | General Counsel | 09.09.2021 |
Ehemalige bekannte Positionen von Zoran Zdraveski
| Unternehmen | Position | Ende |
|---|---|---|
| MAGENTA THERAPEUTICS | General Counsel | 01.04.2021 |
| EPIZYME, INC. | Corporate Officer/Principal | 01.04.2017 |
Ausbildung von Zoran Zdraveski
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
83
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Southern Methodist University
 Southern Methodist University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Suffolk University Law School
 Suffolk University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
